by adminTorusBrand | Aug 3, 2017 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text]Since securing additional funding last fall, AXIM® Biotechnologies has expanded its ongoing new drug research to include treatments for opioid addiction, irritable bowel syndrome, multiple sclerosis, psoriasis and eczema, and...
by adminTorusBrand | Aug 3, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, Aug. 3, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Clinical...
by adminTorusBrand | Aug 2, 2017 | Axim Biotechnologies, Company News, Dixie Botanicals, HempMeds, HempMeds Brasil, HempMeds Mexico
[vc_row][vc_column][vc_column_text]Since 2012, Mediccal Marijuana, Inc. has been recognized as an industry leader in the CBD hemp oil space. As the first company in the world to develop nationally legal CBD hemp oil products, Medical Marijuana, Inc. pioneered the path...
by adminTorusBrand | Jul 27, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, July 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its major investment AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Services...
by adminTorusBrand | Jul 21, 2017 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies has taken the steps necessary to begin Phase II clinical trials on a cannabinoid-based functional chewing gum for the treatment of restless leg syndrome. AXIM® Biotechnologies recently entered into a Services...